Cointime

Gene Techno Science

company

About

Gene Techno Science is engaged in the research and development of biopharmaceutical products and biosimilars in Japan.

  • 11 - 50

Highlights

Total Funding Amount
¥1B
Funding Rounds
2
Investors
4
Investments
1

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
¥500.25M
Industries
Biopharma,Biotechnology,Medical,Nursing and Residential Care,Pharmaceutical
Founded date
Jan 1, 2001
Number Of Employee
11 - 50
Operating Status
Active

Gene Techno Science is engaged in the research and development of biopharmaceutical products and biosimilars in Japan.

The company develops drugs for the treatment of immunological, cardiovascular, ophthalmic, infectious, and renal diseases as well as oncology drugs. It also offers Filgrastim for the treatment of cancer.

Gene Techno Science was founded in 2001 and is headquartered in Sapporo, Japan.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
¥1B
Gene Techno Science has raised a total of ¥1B in funding over 2 rounds. Their latest funding was raised on Jul 7, 2010 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 7, 2010 Series Unknown ¥507.90M 1 — — Detail
Jun 11, 2008 Series Unknown ¥500.25M 3 — — Detail

Investments

Number of Investments
Number of Lead Investments
1
0
Gene Techno Science has made 1 investments. Their most recent investment was on Nov 21, 2019, when Heartseed raised $26M.
Date Company Name
Round Money Raised Industry Lead Investor
Nov 21, 2019 Heartseed
Series B $26M Beauty —

Investors

Number of Lead Investors
Number of Investors
—
4
Gene Techno Science is funded by 4 investors. Daiwa SMBC Capital and Bio-sight Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Daiwa SMBC Capital — Series Unknown
Bio-sight Capital — Series Unknown
Nomura Research and Advisory — Series Unknown
NIF SMBC Ventures — Series Unknown
Cointime
Content
Company